A veteran processor architect striving to regain its glory in the RISC-V architecture arena.MIPSMIPS has been making frequent moves recently. It announced that it will accelerate its designs for edge ...

Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...

Learn how doctors are developing a new platform that uses bacteria and protein design to speed early vaccine testing and ...

DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology ...